Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-7 of 7
Keywords: Baclofen
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Neurology and Neuroscience
Journal:
European Neurology
Eur Neurol (2016) 75 (5-6): 236–243.
Published Online: 10 May 2016
... were patients with at least 1 failed therapy attempt with either baclofen or tizanidine (Group 1) or at least 2 failed therapy attempts with both baclofen and tizanidine (Group 2). Summary: Of 241 patients in the intent-to-treat population, 162 and 57 patients met the criteria for Groups 1 and 2...
Journal Articles
Subject Area:
Neurology and Neuroscience
Journal:
European Neurology
Eur Neurol (1987) 26 (3): 141–144.
Published Online: 06 February 2008
...Robert P. Iacono; Jennifer Linford; Ara Tourian; Reuven Sandyk Baclofen at 20–40 mg/day was used to successfully treat two post-amputation patients who developed continuous complex involuntary movements of the proximal extremity. These autonomous movements were otherwise recalcitrant to therapy...
Journal Articles
Subject Area:
Neurology and Neuroscience
Journal:
European Neurology
Eur Neurol (1985) 24 (6): 380–385.
Published Online: 01 February 2008
...C.F. Terrence; G.H. Fromm; R. Tenicela Baclofen has shown analgesic properties in a number of animal studies but has failed as a conventional analgesic in the human postoperative dental pain model. In order to test baclofen’s analgesic properties in more chronic pain conditions, we selected...
Journal Articles
Subject Area:
Neurology and Neuroscience
Journal:
European Neurology
Eur Neurol (1985) 24 (4): 286–288.
Published Online: 01 February 2008
...R. Sandyk A patient with neuroleptic-induced akathisia was successfully treated with a combination of baclofen (a GABA agonist) and clonazepam (a serotonergic agent). This suggests that agents bypassing the dopaminergic systems may be effective in the treatment of this distressing disorder. ©...
Journal Articles
Subject Area:
Neurology and Neuroscience
Journal:
European Neurology
Eur Neurol (1984) 23 (3): 163–165.
Published Online: 31 January 2008
...R. Sandyk A 58-year-old women with long-standing hemifacial spasm experienced dramatic relief of symptomatology while receiving baclofen (Lioresal®) in a daily dosage of 37.5 mg. Clinical response was noted within 48 h and she remained asymptomatic during 12 months of treatment. No toxic or side...
Journal Articles
Subject Area:
Neurology and Neuroscience
Journal:
European Neurology
Eur Neurol (1984) 23 (1): 51–55.
Published Online: 31 January 2008
...L. Steardo; A. Leo; E. Marano Baclofen (beta-4-chlorophenyl-gamma-aminobutyric acid) shows analgesic properties in rats and resembles carbamazepine and phenytoin in its effects on the spinal trigeminal nucleus of cats. We have, therefore, conducted a clinical trial in 25 subjects, 16 suffering from...
Journal Articles
Subject Area:
Neurology and Neuroscience
Journal:
European Neurology
Eur Neurol (1977) 16 (1-6): 257–262.
Published Online: 29 January 2008
...W. Cendrowski; W. Sobczyk 25 patients with multiple sclerosis (MS) and other spastic disorders, 33 MS patients and 10 control patients with MS were given clonazepam, baclofen or placebo over a period of 5 days to 20 weeks. Both clonazepam and baclofen were significantly more effective than placebo...